Structure Info
- Chemspace ID
- CSSS07096521613 (In-Stock Screening Compounds)
- MFCD
- MFCD34789693, MFCD09997928
- IUPAC Name
- 6-{3-[(4aR,7aS)-hexahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6-yl]propoxy}-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine
- Mol formula
- C24H26ClFN4O4
- Mol weight
- 489 Da
- Catalog Number(s)
- A1964207, AA02ALKR, AG02ALNJ, AR02AMCJ, AT33901, BD01843455, BM53655, BU53655, HY-153110, T73334, TS-09654, Y229199, Y3309397
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.65
- Heavy atoms count
- 34
- Rotatable bond count
- 8
- Number of rings
- 5
- Carbon bond saturation, Fsp3
- 0.416
- Polar surface area (Å)
- 78
- Hydrogen bond acceptors count
- 8
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSS07096521613
Items Overall 16 items from 3 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, € | Qty |
---|---|---|---|---|---|---|
MedChemExpress | 10 days | United States To: | 99 | 5 mg | 216 | |
MedChemExpress | 10 days | United States To: | 99 | 10 mg | 324 | |
MedChemExpress | 10 days | United States To: | 99 | 25 mg | 549 | |
MedChemExpress | 10 days | United States To: | 99 | 50 mg | 784 | |
MedChemExpress | 10 days | United States To: | 99 | 100 mg | 1,098 | |
Description: Names: Larotinib; Product Description: Larotinib is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC 50 of 0.6 nM .; Target: Btk;EGFR;IRAK; CAS: 1438072-11-7 | ||||||
MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 227 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 341 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 25 mg | 578 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 50 mg | 826 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 100 mg | 1,157 | |
Description: Names: Larotinib; Product Description: Larotinib is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC50 of 0.6 nM; Target: Btk;EGFR;IRAK; CAS: 1438072-11-7 | ||||||
Targetmol Chemicals Inc | 30 days | United States To: | 98 | 1 mg | 74 | |
Targetmol Chemicals Inc | 30 days | United States To: | 98 | 5 mg | 179 | |
Targetmol Chemicals Inc | 30 days | United States To: | 98 | 10 mg | 272 | |
Targetmol Chemicals Inc | 30 days | United States To: | 98 | 25 mg | 463 | |
Targetmol Chemicals Inc | 30 days | United States To: | 98 | 50 mg | 662 | |
Targetmol Chemicals Inc | 30 days | United States To: | 98 | 100 mg | 928 | |
Description: Larotinib is an orally active, potent, and broad-spectrum tyrosine kinase inhibitor (TKI) with an IC50 of 0.6 nM for EGFR.; CAS: 1438072-11-7 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire